Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Bemcentinib by BerGenBio for Metastatic Melanoma: Likelihood of Approval
Bemcentinib is under clinical development by BerGenBio and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase II...
Bemcentinib by BerGenBio for Lung Adenocarcinoma: Likelihood of Approval
Bemcentinib is under clinical development by BerGenBio and currently in Phase II for Lung Adenocarcinoma. According to GlobalData, Phase II...
Bemcentinib by BerGenBio for Non-Small Cell Lung Cancer: Likelihood of Approval
Bemcentinib is under clinical development by BerGenBio and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...
Bemcentinib by BerGenBio for Malignant Mesothelioma: Likelihood of Approval
Bemcentinib is under clinical development by BerGenBio and currently in Phase II for Malignant Mesothelioma. According to GlobalData, Phase II...